Baird’s Idexx Laboratories IDXX Stock Holding History

Baird’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$436K	Sell	5,648 -4,968	-47%	-$387K	﹤0.01%	999
2014 Q4	$787K	Buy	10,616 +6,396	+152%	+$449K	0.01%	805
2014 Q3	$249K	Sell	4,220 -530	-11%	-$33.5K	﹤0.01%	1017
2014 Q2	$317K	Buy	4,750 +8	+0.2%	+$509	﹤0.01%	964
2014 Q1	$288K	Buy	4,742 +228	+5%	+$13.6K	﹤0.01%	988
2013 Q4	$240K	Buy	+4,514	New	+$238K	﹤0.01%	1029

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baird's IDXX Position: Q1 2015 in Review

Baird reduced its Idexx Laboratories (IDXX) stake by 47% in Q1 2015, selling an estimated $387K and leaving 5,648 shares worth $436K. The position accounts for ﹤0.01% of the portfolio, ranked #999.

Baird first reported a position in IDXX in Q4 2013 and has held it in 6 quarters since. The position peaked at $787K in Q4 2014. 344 funds tracked by Wall St. Rank hold IDXX as of Q1 2015.

Baird held 5,648 shares of Idexx Laboratories worth $436K as of Q1 2015.
Baird sold 4,968 Idexx Laboratories shares in Q1 2015, an estimated $387K.
Idexx Laboratories made up ﹤0.01% of Baird's portfolio in Q1 2015, its #999 holding.
Baird first reported a position in Idexx Laboratories in Q4 2013 and has held it in 6 quarters since.
Baird's Idexx Laboratories position peaked at $787K in Q4 2014.
344 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.